These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6164218)

  • 1. Polymorphonuclear leukocyte chemotaxis in dermatitis herpetiformis.
    Esca SA; Pehamberger H; Silny W; Holubar K
    Acta Derm Venereol; 1981; 61(1):61-3. PubMed ID: 6164218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The chemotactic effect of blister roof, blister fluid and blister floor on polymorphonuclear leucocytes in dermatitis herpetiformis Duhring (author's transl)].
    Bork K
    Arch Dermatol Forsch; 1975; 252(1):47-51. PubMed ID: 1130827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis.
    Minta JO; Kovacs EK; Sukenik S; Lee P
    J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil chemotaxis in patients with atopic dermatitis without infection.
    Dahl MV; Cates KL; Quie PG
    Arch Dermatol; 1978 Apr; 114(4):544-6. PubMed ID: 646365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.
    Stendahl O; Molin L; Dahlgren C
    J Clin Invest; 1978 Jul; 62(1):214-20. PubMed ID: 207742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic factors as cause of polyleukocyte urine in urinary tract infection: chemotactic activity of urinary protein fraction.
    Tsujimura S; Otaguro K; Sasaki M; Tanaka R
    Invest Urol; 1980 Jan; 17(4):269-72. PubMed ID: 7351359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the PMN chemotaxis in periodontal disease.
    Zafiropoulos GG; Flores-de-Jacoby L; Wirth J; Nisengard RJ; Havemann K; Kolb G
    Dtsch Zahn Mund Kieferheilkd Zentralbl; 1991; 79(1):15-22. PubMed ID: 9239950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of F(1+2) prothrombin fragments and thrombin - antithrombin III (TAT) complexes in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Gwieździński Z; Kotschy M
    Med Sci Monit; 2002 Aug; 8(8):BR324-7. PubMed ID: 12165736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro attraction of polymorphonuclear leucocytes by Trichomonas vaginalis.
    Mason PR; Forman L
    J Parasitol; 1980 Dec; 66(6):888-92. PubMed ID: 7012294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zinc levels in the leukocytes and serum of patients with psoriasis during the active phase and during remission associated with the chemotactic activity of polymorphonuclear leukocytes].
    Wasik F; Baran E; Walów B; Sierawska M; Waniewska I; Kaniowska E; Podwiński P; Andrzejak R
    Przegl Dermatol; 1985; 72(3):237-42. PubMed ID: 4081068
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutrophil chemotaxis and serum factor modulation in Brazilian periodontitis patients.
    Hidalgo MM; Avila-Campos MJ; Trevisan W; Mocelin TT; Itano EN
    Arch Med Res; 1997; 28(4):531-5. PubMed ID: 9428579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE levels and PMN chemotaxis in atopic dermatitis.
    Galli E; Rossi P; Fiore L; Perlini R; Celiboni F; Betti P; Businco L
    Allergol Immunopathol (Madr); 1983; 11(3):189-94. PubMed ID: 6605080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoglobulin (IgG) inhibitor of polymorphonuclear leukocyte motility in a patient with recurrent infection.
    Kramer N; Perez HD; Goldstein IM
    N Engl J Med; 1980 Nov; 303(22):1253-8. PubMed ID: 7421962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the function of polymorphonuclear neutrophils in patients with glomerulonephritis. I. Influence of nitrogen metabolites retention, in renal failure on functional activity of polymorphonuclear neutrophils.
    Szewczyk Z; Kuźniar J; Kopeć W; Wrezlewicz W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):459-63. PubMed ID: 749798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.